Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations. - Wikidata - wikimedia - TriplyDB

Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations.

Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations.

http://www.wikidata.org/entity/Q37379689

about

Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis Classifying married adults diagnosed with alpha-1 antitrypsin deficiency based on spousal communication patterns using latent class analysis: insights for intervention Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression.BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair.BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis.Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis.

P2860

Q26823419-8AA0D0D8-3374-41B8-998C-4C801C077155 Q33555916-8E446461-AC51-40DD-A839-BF9B24D229C0 Q34038170-ABC3F104-4D36-4795-99D6-1DA530212046 Q36009795-ACF0D3F4-7E80-401E-998F-EEBF31A37898 Q37688494-4AD5DF8F-20A0-4B6E-A7C5-B5A465492BA6 Q38789729-B3058AB7-40F5-4F03-BAAF-094B723FCD41 Q38980036-13DA1F6F-63AC-487B-86A9-F787F215548D Q48005561-C56EF7E2-2E50-4D38-9C4D-33476FD7CF9B Q50912716-887F0295-339D-4C60-A368-5DB109438EC1 Q51208435-C8D5857A-D66F-4E50-9FC1-DF9099B5C855

P2860

Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations.

http://www.wikidata.org/entity/Q37379689

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Outcome of metastatic breast c ...... ut deleterious BRCA mutations.

@en

Outcome of metastatic breast c ...... ut deleterious BRCA mutations.

@nl

type

label

Outcome of metastatic breast c ...... ut deleterious BRCA mutations.

@en

Outcome of metastatic breast c ...... ut deleterious BRCA mutations.

@nl

prefLabel

Outcome of metastatic breast c ...... ut deleterious BRCA mutations.

@en

Outcome of metastatic breast c ...... ut deleterious BRCA mutations.

@nl

P1433

Q37379689-4A052424-34C1-4ACD-85A4-82B4A8F4DA30

P1476

Q37379689-416A853E-4D60-4FA1-B769-3779EEE4CB5B

P2093

Q37379689-1B5D8549-453A-488D-80CB-DCBE4F2EB3EC

Q37379689-1D7E452C-E9E5-4DD3-B9EE-3B462EDB136E

Q37379689-20F6AB94-87E2-475C-A48B-8083F3B2695C

Q37379689-3CFA0CA2-E113-46AB-9E56-A36EC6995803

Q37379689-566FB6C3-8F5D-40B8-AF9D-7D955BDE572D

Q37379689-5876CA4C-8FA6-4254-A003-DE0D246B8752

Q37379689-65C4AABD-0BF1-4B35-A67B-3720F9416CE2

Q37379689-8383D493-B603-49C2-9DB8-C2B73E433D2F

Q37379689-856B300C-4196-4D22-B800-B18EC602CB38

Q37379689-A1189397-8318-4370-B1CE-F22F5E0BEE3D

P2860

Q37379689-02490F70-4816-4E73-8051-56E61993EF49

Q37379689-066005C6-28BE-47E3-92FB-2C3C50007029

Q37379689-18B09D54-B79E-4662-AB64-94D7767DDF6C

Q37379689-1CA7ED73-4304-4BDD-8784-752E20F53204

Q37379689-32CCE105-3550-44DF-B6A6-53FE6986C31E

Q37379689-33131ABC-25BD-4BD4-B483-512A4A04ECB5

Q37379689-3C42F7D4-164A-4723-A6DA-245D9334BE11

Q37379689-4B8270E7-DE09-4549-AAA5-6363747E8F32

Q37379689-4C2B578A-C128-43B8-99CD-04AD55642379

Q37379689-4C45DFAF-145B-418F-9DEC-57F1028B3BA1

P2888

Q37379689-26D453B2-CDAE-40E9-90F4-2DF8AE525DE7

P304

Q37379689-7D12BB4A-CFA2-4B7D-B5D3-5D0B1BA7FCD0

P31

Q37379689-B5CB39E9-9891-4CF7-BFBE-116BEF182B61

P356

Q37379689-F27D8EEF-18BA-4764-81B8-CC5484977D8A

P433

Q37379689-E008427C-7F26-441E-9D23-2D19FF5B28D9

P478

Q37379689-68DB2BD9-39BD-4C40-950D-073CB19B180C

P577

Q37379689-5FDD3915-51B7-431E-BD13-D8F2FBFA834D

P698

Q37379689-FF2585C7-0C1F-4A7D-9136-AF2F77259B6D

P932

Q37379689-E54E2CE8-6993-40CA-88C4-EF0C111F9A1C

P356

S10585-013-9567-8

P1433

Clinical & Experimental Metastasis

P1476

Outcome of metastatic breast c ...... ut deleterious BRCA mutations.

@en

P2093

A M Gutierrez-Barrera

http://www.w3.org/2001/XMLSchema#string

B K Arun

http://www.w3.org/2001/XMLSchema#string

D J Booser

http://www.w3.org/2001/XMLSchema#string

G N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

H Lin

http://www.w3.org/2001/XMLSchema#string

J K Litton

http://www.w3.org/2001/XMLSchema#string

M Green

http://www.w3.org/2001/XMLSchema#string

N Elsayegh

http://www.w3.org/2001/XMLSchema#string

N K Ibrahim

http://www.w3.org/2001/XMLSchema#string

P K Morrow

http://www.w3.org/2001/XMLSchema#string

P2860

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.

Genes associated with breast cancer metastatic to bone.

Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.

P2888

s10585-013-9567-8

P304

631-642

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10585-013-9567-8

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23370825

http://www.w3.org/2001/XMLSchema#string

P932

3857726

http://www.w3.org/2001/XMLSchema#string